PBH - Prestige Consumer Healthcare Inc
Close
74.64
0.640 0.857%
Share volume: 232,419
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$74.00
0.64
0.87%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-02 | 2023-05-05 | 2023-08-03 | 2023-11-02 | 2024-02-08 | 2024-05-15 | |
| Assets | |||||||||
| Total Assets | 3.682 B | 3.679 B | 3.750 B | 3.354 B | 3.346 B | 3.333 B | 3.340 B | 3.318 B | |
| Current Assets | 324.615 M | 336.653 M | 408.847 M | 391.743 M | 391.758 M | 388.198 M | 393.786 M | 375.043 M | |
| Inventories | 133.768 M | 140.505 M | 158.522 M | 162.121 M | 169.849 M | 161.283 M | 148.637 M | 138.717 M | |
| Other Current Assets | 9.527 M | 7.714 M | 6.886 M | 4.117 M | 9.379 M | 8.392 M | 7.246 M | 13.082 M | |
| Short Term Investments | 9.527 M | 7.714 M | 6.886 M | 4.117 M | 9.379 M | 8.392 M | 7.246 M | 13.082 M | |
| Total Receivables | 145.451 M | 145.992 M | 157.081 M | 167.016 M | 157.950 M | 158.456 M | 174.288 M | 176.775 M | |
| Current Cash | 35.869 M | 42.442 M | 86.358 M | 58.489 M | 54.580 M | 60.067 M | 63.615 M | 46.469 M | |
| Total Non-current Assets | 3.358 B | 3.342 B | 3.341 B | 2.962 B | 2.954 B | 2.945 B | 2.946 B | 2.943 B | |
| Property Plant Equipment | 70.393 M | 69.947 M | 69.569 M | 70.412 M | 69.979 M | 70.700 M | 70.356 M | 76.507 M | |
| Other Assets | 8.936 M | 8.106 M | 8.018 M | 7.205 M | 6.802 M | 6.732 M | 8.509 M | 7.266 M | |
| Intangible Assets | 2.683 B | 2.671 B | 2.670 B | 2.342 B | 2.336 B | 2.328 B | 2.329 B | 2.321 B | |
| Goodwill | 576.794 M | 575.566 M | 576.602 M | 527.553 M | 527.458 M | 526.860 M | 527.878 M | 527.733 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.682 B | 3.679 B | 3.750 B | 3.354 B | 3.346 B | 3.333 B | 3.340 B | 3.318 B | |
| Total liabilities | 2.097 B | 2.059 B | 2.063 B | 1.907 B | 1.865 B | 1.797 B | 1.739 B | 1.663 B | |
| Total current liabilities | 155.349 M | 152.308 M | 160.176 M | 160.715 M | 147.271 M | 129.704 M | 127.437 M | 117.048 M | |
| Accounts Payable | 58.110 M | 56.196 M | 64.254 M | 62.743 M | 57.861 M | 44.381 M | 39.339 M | 38.979 M | |
| Other liabilities | 8.918 M | 8.877 M | 8.872 M | 8.165 M | 8.183 M | 8.896 M | 8.919 M | 9.185 M | |
| Current long term debt | 2.772 M | 2.793 M | 2.814 M | 2.834 M | 2.855 M | 2.876 M | 2.188 M | 1.494 M | |
| Long term debt | 1.476 B | 1.441 B | 1.426 B | 1.347 B | 1.318 B | 1.263 B | 1.200 B | 1.126 B | |
| Other liabilities | 8.918 M | 8.877 M | 8.872 M | 8.165 M | 8.183 M | 8.896 M | 8.919 M | 9.185 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.585 B | 1.620 B | 1.687 B | 1.447 B | 1.480 B | 1.536 B | 1.601 B | 1.655 B | |
| Common stock | 50.264 M | 49.804 M | 49.693 M | 49.795 M | 49.767 M | 49.687 M | 49.740 M | 49.834 M | |
| Retained earnings | 1.269 B | 1.320 B | 1.372 B | 1.132 B | 1.185 B | 1.239 B | 1.292 B | 1.341 B |